100 related articles for article (PubMed ID: 20171438)
21. Systemic therapy for psoriasis.
Lee M; Kalb RE
Dermatol Nurs; 2008 Apr; 20(2):105-11; quiz 112. PubMed ID: 18549125
[TBL] [Abstract][Full Text] [Related]
22. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
23. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
Smith CH; Anstey AV; Barker JN; Burden AD; Chalmers RJ; Chandler DA; Finlay AY; Griffiths CE; Jackson K; McHugh NJ; McKenna KE; Reynolds NJ; Ormerod AD;
Br J Dermatol; 2009 Nov; 161(5):987-1019. PubMed ID: 19857207
[No Abstract] [Full Text] [Related]
24. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.
Wahie S; Alexandroff A; Reynolds NJ
Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606
[No Abstract] [Full Text] [Related]
25. Serum sickness due to infliximab in a patient with psoriasis.
Krishnan RS; Hsu S
J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
[TBL] [Abstract][Full Text] [Related]
26. Adverse reactions of biological therapy for psoriasis.
Brănişteanu DE; Voicu CM; Creţu A; Dimitriu A; Luca MC; Sălăvăstru CM
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):38-44. PubMed ID: 25970940
[TBL] [Abstract][Full Text] [Related]
27. A severe complication of anti-TNF alfa treatment.
Fabroni C; Gori A; Prignano F; Lotti T
G Ital Dermatol Venereol; 2010 Dec; 145(6):775-7. PubMed ID: 21139554
[TBL] [Abstract][Full Text] [Related]
28. Adalimumab: new indication. A last resort for treating plaque psoriasis: just another TNF alpha antagonist.
Prescrire Int; 2008 Dec; 17(98):240. PubMed ID: 19422152
[No Abstract] [Full Text] [Related]
29. Psoriasis induced by anti-tumor necrosis factor therapy: a class effect?
Richette P; Viguier M; Bachelez H; Bardin T
J Rheumatol; 2007 Feb; 34(2):438-9. PubMed ID: 17304662
[No Abstract] [Full Text] [Related]
30. Treatment of pustular psoriasis with infliximab.
Weishaupt C; Metze D; Luger TA; Ständer S
J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
[TBL] [Abstract][Full Text] [Related]
31. Potential complications associated with the use of biologic agents for psoriasis.
Zeichner JA; Lebwohl M
Dermatol Clin; 2007 Apr; 25(2):207-13, vii. PubMed ID: 17430757
[TBL] [Abstract][Full Text] [Related]
32. Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.
Vergou T; Moustou AE; Maniateas A; Stratigos AJ; Katsambas A; Antoniou C
Int J Dermatol; 2010 Oct; 49(10):1215-7. PubMed ID: 20883414
[No Abstract] [Full Text] [Related]
33. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
34. Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis.
Takahashi MD; Castro LG; Romiti R
Br J Dermatol; 2007 Oct; 157(4):828-31. PubMed ID: 17711530
[No Abstract] [Full Text] [Related]
35. The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review.
Grinblat B; Scheinberg M
Semin Arthritis Rheum; 2008 Feb; 37(4):251-5. PubMed ID: 17640718
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
37. Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis.
Zargari O
Dermatol Online J; 2005 Dec; 11(3):21. PubMed ID: 16409917
[TBL] [Abstract][Full Text] [Related]
38. Development of primary varicella infection during infliximab treatment for psoriasis.
Balato N; Gaudiello F; Balato A; Ayala F
J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027
[No Abstract] [Full Text] [Related]
39. [Our experience with infliximab in reclacitrant cases of psoriasis].
Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
[TBL] [Abstract][Full Text] [Related]
40. Severe neutrophilia induced by infliximab for psoriasis.
de Oliveira JP; Levy A; Morel P; Guibal F
Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
